Prabhakar Baliga to Muromonab-CD3
This is a "connection" page, showing publications Prabhakar Baliga has written about Muromonab-CD3.
Connection Strength
0.152
-
Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
Score: 0.143
-
Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function. Clin Transplant. 1997 Aug; 11(4):294-8.
Score: 0.009